Diffregen Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Diffregen General Information

Description

Developer of therapeutics drugs designed to stop the progression of cancer and activate the healthy immune system. The company uses active ingredients that are based on Angiocidin, a protein that has been shown to activate monocytes and drive terminal differentiation of leukemia cells, enabling acute myeloid leukemia patients to get proper treatment against cancer.

Contact Information

Website
www.diffregen.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 440 Coldstream Drive
  • Berwyn, PA 19312
  • United States
+1 (610)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 440 Coldstream Drive
  • Berwyn, PA 19312
  • United States
+1 (610)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diffregen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 21-Feb-2018 Completed Startup
2. Grant 01-Jan-2013 Completed Startup
1. Grant 01-Jan-2011 $100K Completed Startup
To view Diffregen’s complete valuation and funding history, request access »

Diffregen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
MassChallenge Accelerator/Incubator
U.S. Department of Health and Human Services Government
Science Center Accelerator/Incubator
To view Diffregen’s complete investors history, request access »

Ready to get started?

Request a free trial

Diffregen FAQs

  • When was Diffregen founded?

    Diffregen was founded in 2011.

  • Where is Diffregen headquartered?

    Diffregen is headquartered in Berwyn, PA.

  • What industry is Diffregen in?

    Diffregen’s primary industry is Drug Discovery.

  • Is Diffregen a private or public company?

    Diffregen is a Private company.

  • What is Diffregen’s current revenue?

    The current revenue for Diffregen is .

  • Who are Diffregen’s investors?

    MassChallenge, U.S. Department of Health and Human Services, and Science Center have invested in Diffregen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »